Advertisement

Shuttle Pharmaceuticals Holdings, Inc. SHPH

Set alert

Price alert · SHPH

All alert types
5.15 USD -0.08 -1.53%

At close · Oct 30

5.15 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
5.25 × 2
Ask
5.29 × 2
4.80 Day range 5.42
2.78 52-week range 31.00
YTD
-71.39%
1 year
-83.11%
Open
5.35
Prev close
5.23
Mkt cap
24.54M
Vol
20.48K
Avg vol
120.11K
EPS
-16.87
P/E
0.00
Div yield
0.00%
More statistics
Low
4.80
High
5.42
Forward P/E
0.00
Beta
0.74
Short ratio
0.25
Inst. own
1.81%
Dividend
0.00
Ex-div date
50-d avg
1.06
200-d avg
2.42
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Jun 16, 2025Split: 1 for 25
  • Jun 11, 2026Split: 1 for 10
Signals (68)
NameDateAgo
MACD: Sell SignalOct 21, 20261 week ago
RSI: OverboughtOct 12, 20262 weeks ago
RSI: OverboughtOct 8, 20263 weeks ago
SMA: BullishSep 22, 20261 month ago
MACD: Buy SignalSep 22, 20261 month ago
SMA: BearishSep 2, 20261 month ago
SMA: BullishSep 1, 20262 months ago
SMA: BearishAug 28, 20262 months ago
SMA: BullishAug 27, 20262 months ago
SMA: BearishAug 24, 20262 months ago
MACD: Sell SignalAug 20, 20262 months ago
SMA: BullishAug 5, 20262 months ago
MACD: Buy SignalJun 23, 20264 months ago
MACD: Sell SignalJun 18, 20264 months ago
MACD: Buy SignalJun 17, 20264 months ago
RSI: OversoldJun 15, 20264 months ago
MACD: Sell SignalJun 11, 20264 months ago
MACD: Buy SignalJun 10, 20264 months ago
RSI: OversoldJun 5, 20264 months ago
SMA: BearishMay 1, 20266 months ago
MACD: Sell SignalMay 1, 20266 months ago
SMA: BullishApr 23, 20266 months ago
SMA: BearishApr 22, 20266 months ago
SMA: BullishApr 16, 20266 months ago
MACD: Buy SignalApr 6, 20266 months ago
MACD: Sell SignalMar 30, 20267 months ago
RSI: OversoldMar 27, 20267 months ago
MACD: Buy SignalMar 6, 20267 months ago
SMA: BearishFeb 4, 20268 months ago
MACD: Sell SignalFeb 3, 20269 months ago
SMA: BullishJan 20, 20269 months ago
MACD: Buy SignalJan 20, 20269 months ago
MACD: Sell SignalJan 13, 20269 months ago
MACD: Buy SignalDec 3, 202511 months ago
RSI: OversoldNov 19, 202511 months ago
RSI: OversoldNov 13, 202511 months ago
RSI: OversoldNov 7, 202511 months ago
SMA: BearishOct 16, 20251 year ago
MACD: Sell SignalOct 13, 20251 year ago
MACD: Buy SignalOct 3, 20251 year ago
SMA: BullishOct 1, 20251 year ago
SMA: BearishSep 30, 20251 year ago
MACD: Sell SignalSep 30, 20251 year ago
SMA: BullishSep 17, 20251 year ago
RSI: OverboughtSep 17, 20251 year ago
MACD: Buy SignalAug 22, 20251 year ago
MACD: Sell SignalAug 15, 20251 year ago
MACD: Buy SignalAug 14, 20251 year ago
MACD: Sell SignalJul 31, 20251 year ago
SMA: BearishJul 16, 20251 year ago
SMA: BullishJul 15, 20251 year ago
MACD: Buy SignalJun 20, 20251 year ago
MACD: Sell SignalJun 17, 20251 year ago
RSI: OversoldJun 3, 20251 year ago
MACD: Buy SignalMay 29, 20251 year ago
MACD: Sell SignalMay 21, 20251 year ago
RSI: OversoldMay 21, 20251 year ago
MACD: Buy SignalMay 14, 20251 year ago
MACD: Sell SignalMay 13, 20251 year ago
RSI: OversoldMay 13, 20251 year ago
MACD: Buy SignalApr 25, 20251 year ago
MACD: Sell SignalApr 15, 20251 year ago
RSI: OversoldApr 15, 20251 year ago
MACD: Buy SignalMar 21, 20251 year ago
RSI: OversoldMar 7, 20251 year ago
MACD: Sell SignalJan 29, 20251 year ago
SMA: BearishJan 28, 20251 year ago
SMA: BullishJan 21, 20251 year ago

Key statistics

Market cap
2.62M
Enterprise value
1.20M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.00
Price / book
0.35
EPS (TTM)
-4.25
Beta
0.74
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-2.49M
Total cash
2.34M
Total debt
1.16M
Return on equity
-186.00%
Shares outstanding
3.66M
Short % of float
27.91%
50-day average
1.06
200-day average
2.42

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
SHPH Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SHPH Net income — quarterly -3.15M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SHPH EPS — quarterly -3.10
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

About Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States

News

Your note

Sign in to keep a note on SHPH — it syncs with the Stock Master app.

Insider holders

SHPH insider holders
InsiderRelationLatest transactionDateShares held
ADKINS WILLIAM HFounderSaleDec 28, 2022184,071
BROWN MILTONDirectorSaleDec 12, 20231,094,610
DRITSCHILO ANATOLYChief Executive OfficerStock GiftAug 13, 20230
DRITSCHILO PETERPresidentSaleDec 28, 20226,560
JACOBS BETTEDirectorSaleDec 12, 202327,064
JUNG MIRAOfficerSaleDec 28, 20221,071,390

Institution ownership

SHPH institution ownership
Holder% heldSharesValueReported
HRT Financial LP0.71%25,86618.49KSep 29, 2024
Tower Research Capital LLC (TRC)0.11%3,8582.76KSep 29, 2024
Federation Des Caisses Desjardins Du Quebec0.00%6345Sep 29, 2024
Bank of America Corporation0.00%96Sep 29, 2024

Fund ownership

SHPH fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.09%3,1512.25KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.02%616440Oct 30, 2024
Fidelity Series Total Market Index Fund0.01%501358Oct 30, 2024
Advertisement